glp 1 agonists and anesthesia 🇬🇧 Perioperative Management of New Popular Agents: GLP-1 (GLP-1 RA: semaglutide, tirzepatide) These drugs delay gastric emptying → patients may have a “full stomach” despite fasting This increases risk of regurgitation Physiology of GLP-1 secretion and

AK, CVS and YH drafted the manuscript

Both types of medications effectively lower blood glucose, but long-acting drugs may dominate the market due to higher patient compliance

A randomized, double-blind, phase 2b proof-of-concept clinical trial in early alzheimers disease with lecanemab, an anti-abeta protofibril antibody

Clinical decision-making should consider the totality of cardiovascular risk factors rather than focusing exclusively on lipid parameters

Factors to Consider When Choosing a GLP-1 Agonist Your Goals: For significant weight loss, options like semaglutide or tirzepatide are most effective

Because the mechanism of action of SGLT-2 inhibitors is dependent on kidney function, these agents are not recommended for patients with diminished renal function